Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Adagio Therapeutics, Inc. | Director | Common Stock | 1.99M | $7.84M | $3.95 | Aug 5, 2021 | Direct |
Xilio Therapeutics, Inc. | PRESIDENT AND CEO, Director | Restricted Stock Units | 177K | $1.81M | $10.24 | Jan 1, 2024 | Direct |
Xilio Therapeutics, Inc. | PRESIDENT AND CEO, Director | Stock Option (right to buy) | 474K | May 1, 2024 | Direct | ||
Adagio Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 35.6K | Aug 5, 2021 | Direct | ||
X4 Pharmaceuticals, Inc | Director | Stock Option (right to buy) | 6K | Jun 2, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
XLO | Xilio Therapeutics, Inc. | May 1, 2024 | 1 | $0 | 4 | May 3, 2024 | PRESIDENT AND CEO, Director |
XLO | Xilio Therapeutics, Inc. | Jan 1, 2024 | 1 | $0 | 4 | Jan 3, 2024 | PRESIDENT AND CEO, Director |
XLO | Xilio Therapeutics, Inc. | Aug 16, 2023 | 1 | $0 | 4 | Aug 18, 2023 | CEO, Director |
XLO | Xilio Therapeutics, Inc. | Jan 1, 2023 | 1 | $0 | 4 | Jan 4, 2023 | CEO, Director |
XLO | Xilio Therapeutics, Inc. | Feb 22, 2022 | 1 | $0 | 4 | Feb 24, 2022 | CEO AND PRESIDENT, Director |
XLO | Xilio Therapeutics, Inc. | Dec 22, 2021 | 1 | $0 | 4/A | Jan 4, 2022 | CEO AND PRESIDENT, Director |
XLO | Xilio Therapeutics, Inc. | Oct 21, 2021 | 1 | $0 | 4 | Oct 25, 2021 | CEO and President, Director, 10%+ Owner |
XLO | Xilio Therapeutics, Inc. | Oct 21, 2021 | 0 | $0 | 3 | Oct 21, 2021 | CEO and President, Director, 10%+ Owner |
IVVD | Adagio Therapeutics, Inc. | Aug 5, 2021 | 1 | $0 | 4 | Aug 9, 2021 | Director |
IVVD | Adagio Therapeutics, Inc. | Aug 5, 2021 | 0 | $0 | 3 | Aug 5, 2021 | Director |
XFOR | X4 Pharmaceuticals, Inc | Jun 2, 2021 | 1 | $57K | 4 | Jun 2, 2021 | Director |